Literature DB >> 22014046

Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy?

Seog Yun Park1, Hee Jin Chang, Dae Yong Kim, Kyung Hae Jung, Sun Young Kim, Ji Won Park, Jae Hwan Oh, Seok-Byung Lim, Hyo Seong Choi, Seung-Yong Jeong.   

Abstract

AIMS: To assess the efficacy of the step section for determination of pathological complete response (pCR) in rectal cancer treated with preoperative chemoradiotherapy (CRT). METHODS AND
RESULTS: Of 709 patients with rectal cancer who received preoperative CRT, 88 were initially diagnosed as having pCR. These 88 patients were re-evaluated after two-level step sections of the entire tumour by using Dworak's regression grade. Additional serial step sections revealed residual tumour cells in seven of 88 patients (7.95%), all of whom were upgraded to regression grade 3 (near total regression) from regression grade 4 (total regression). Of these seven patients, one (14.3%) showed tumour recurrence, compared with 11 of 81 (13.6%) patients with a final regression grade of 4. Neither recurrence rate nor disease-free survival rate differed significantly between these two groups (P > 0.5). Calcification was significantly more frequent in grade 3 than in grade four patients (71.4% versus 32.1%; P = 0.037), and acellular mucin pools were associated with better disease-free survival (P = 0.022).
CONCLUSIONS: Stratifying patient outcome by final regression grade after step section did not yield different outcomes in patients with initial pCR. If residual tumour cells are not identified on initial meticulous examination, further processing of step sections is not necessary. 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014046     DOI: 10.1111/j.1365-2559.2011.03980.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

Review 1.  Pathologic assessment of gastrointestinal tract and pancreatic carcinoma after neoadjuvant therapy.

Authors:  Reetesh K Pai; Rish K Pai
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

2.  One-level step section histological analysis is insufficient to confirm complete pathological response after neoadjuvant chemoradiation for rectal cancer.

Authors:  M A Pereira; A R Dias; S F Faraj; C S R Nahas; A R Imperiale; C F S Marques; G C Cotti; B C Azevedo; S C Nahas; E S de Mello; U Ribeiro
Journal:  Tech Coloproctol       Date:  2017-08-17       Impact factor: 3.781

3.  Deeper sections reveal residual tumor cells in rectal cancer specimens diagnosed with pathological complete response following neoadjuvant treatment.

Authors:  Lasse Slumstrup; Susanne Eiholm; Astrid Louise Bjørn Bennedsen; Dea Natalie Munch Jepsen; Ismail Gögenur; Anne-Marie Kanstrup Fiehn
Journal:  Virchows Arch       Date:  2022-01-31       Impact factor: 4.064

4.  Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment.

Authors:  Monique Maas; Doenja M J Lambregts; Patty J Nelemans; Luc A Heijnen; Milou H Martens; Jeroen W A Leijtens; Meindert Sosef; Karel W E Hulsewé; Christiaan Hoff; Stephanie O Breukink; Laurents Stassen; Regina G H Beets-Tan; Geerard L Beets
Journal:  Ann Surg Oncol       Date:  2015-07-22       Impact factor: 5.344

5.  What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?

Authors:  Soo Hee Kim; Hee Jin Chang; Dae Yong Kim; Ji Won Park; Ji Yeon Baek; Sun Young Kim; Sung Chan Park; Jae Hwan Oh; Ami Yu; Byung-Ho Nam
Journal:  Cancer Res Treat       Date:  2015-10-22       Impact factor: 4.679

6.  Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?

Authors:  Luca Reggiani Bonetti; Simona Lionti; Federica Domati; Valeria Barresi
Journal:  World J Gastroenterol       Date:  2017-02-28       Impact factor: 5.742

7.  Extramural vascular invasion and response to neoadjuvant chemoradiotherapy in rectal cancer: Influence of the CpG island methylator phenotype.

Authors:  Jeremy Stuart Williamson; Huw Geraint Jones; Namor Williams; Anthony Paul Griffiths; Gareth Jenkins; John Beynon; Dean Anthony Harris
Journal:  World J Gastrointest Oncol       Date:  2017-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.